Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

V Gebbia1 E Maiello2 F Giuliani3 N Borsellino4 M Caruso4 G Di Maggio2 F Ferraù5 R Bordonaro6 F Verderame7 P Tralongo8 L Di Cristina9 R Agueli1 P Russo1 and G Colucci3

首页> 外文期刊>Annals of Oncology >Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

【24h】

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

机译：晚期胰腺癌的二线化疗：Gruppo Oncologico Italia Meridionale在临床实践中对FOLFOX4方案的活性和安全性的多中心调查

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: In daily clinical practice second-line chemotherapy (SLCT) is frequently given to patients with advanced pancreatic cancer failing gemcitabine-based first-line chemotherapy without solid scientific support.

机译：背景：在日常临床实践中，经常接受二线化疗（SLCT）的晚期胰腺癌患者因吉西他滨为基础的一线化疗失败而没有坚实的科学支持。

著录项

来源
《Annals of Oncology》 |2007年第6期|124-127|共4页
作者
V Gebbia1 E Maiello2 F Giuliani3 N Borsellino4 M Caruso4 G Di Maggio2 F Ferraù5 R Bordonaro6 F Verderame7 P Tralongo8 L Di Cristina9 R Agueli1 P Russo1 and G Colucci3;
展开▼
作者单位

Department of Experimental Oncology and Clinical Applications University of Palermo La Maddalena Clinic for Cancer Palermo;

IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo;

Istituto Oncologico Bari;

Centro Catanese di Oncologia—Humanitas Catania;

Ospedale San Vincenzo Taormina;

Ospedale Garibaldi Catania;

Ospedale Civile Sciacca;

Ospedale De Maria Avola;

Ospedale di Castelvetrano AULS 9 Trapani Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献

1. Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. [J] . Gebbia V, Maiello E, Giuliani F, Annals of oncology: official journal of the European Society for Medical Oncology . 2007,第Suppla6期

机译：晚期胰腺癌的二线化疗：Gruppo Oncologico Italia Meridionale在临床实践中对FOLFOX4方案的活性和安全性的多中心调查。
2. Second-line chemotherapy in advanced cancer of the pancreas: A multicenter survey of the Gruppo Oncologico Italia Meridonale on the activity and safety of the folfiri regimen in clinical practice [J] . C. Arcara, E. Maiello, Giuliani, European Journal of Cancer Supplements . 2008,第14期

机译：胰腺癌的二线化疗：Gruppo Oncologico Italia Meridonale在临床实践中对folfiri方案的活性和安全性的多中心调查
3. SECOND-LINE CHEMOTHERAPY IN ADVANCED CANCER OF THE PANCREAS: A MULTICENTER SURVEY OF THE GRUPPO ONCO-LOGICO ITALIA MERIDONALE ON THE ACTIVITY AND SAFETY OF THE FOLFIRI REGIMEN IN CLINICAL PRACTICE [J] . C.Arcara, E. Maiello, Giuliani European Journal of Cancer Supplements . 2008,第14期

机译：胰腺癌的二线化疗：GRUPPO ONCO-LOGICO ITALIA MERIDONALE在临床实践中对FOLFIRI方案的活性和安全性的多中心研究
4. A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study [O] . P. Vici, M. Brandi, F. Giotta, -1

机译：高剂量表柔比星联合环磷酰胺（EC）与多西他赛联合EC联合治疗淋巴结阳性乳腺癌的多中心III期前瞻性随机试验。 GOIM（Gruppo Oncologico Italia Meridionale）9902研究
5. Second-line chemotherapy in advanced cancer of the pancreas: A multicenter survey of the Gruppo Oncologico Italia Meridonale on the activity and safety of the folfiri regimen in clinical practice [O] . Arcara C., Maiello E., Giuliani, 2008

机译：胰腺癌的二线化疗：Gruppo Oncologico Italia Meridonale在临床实践中对folfiri方案的活性和安全性的多中心调查

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

摘要

著录项

相似文献

相关主题

期刊订阅